BACKGROUND: This study investigated the agreement between self-reports from pediatric brain tumor patients and proxy reports from their parents regarding the patients' quality of life (QOL), as assessed using a brain tumor-specific QOL assessment tool, the Pediatric Functional Assessment of Cancer Therapy-Childhood Brain Tumor Survivors (pedsFACT-BrS) questionnaire. The authors expected moderate correlation and similar mean scores between patient and parent reports. METHODS: The pedsFACT-BrS for those aged 7 to 18 years was completed by 351 brain tumor patients (166 children and 185 adolescents), and the parent proxy reports were completed by 351 mother proxies and 37 father proxies. Statistical analyses, including the Pearson product-moment correlation coefficient, intraclass correlation, and comparison of group means, were used to compare the 33 items shared by all 4 versions of the pedsFACT-BrS. RESULTS: The correlation between reports completed by pediatric patients and their parent proxies was significant (P=.59-.84), whereas that between the reports of adolescent patients and their parent proxies was slightly weaker (P=.47-.78). The patient and parent proxy reports showed moderate-to-good agreement and yielded similar mean scores in both the child and adolescent brain tumor patient groups; the sole exception was a difference in emotional well-being scores. CONCLUSIONS: The results indicate that proper use of the pedsFACT-BrS for patients and their parent proxies can provide clinicians with valid information about the overall QOL of child and adolescent brain tumor patients, including both their general health and their brain tumor-specific well-being. Copyright (c) 2010 American Cancer Society.
BACKGROUND: This study investigated the agreement between self-reports from pediatric brain tumorpatients and proxy reports from their parents regarding the patients' quality of life (QOL), as assessed using a brain tumor-specific QOL assessment tool, the Pediatric Functional Assessment of Cancer Therapy-Childhood Brain Tumor Survivors (pedsFACT-BrS) questionnaire. The authors expected moderate correlation and similar mean scores between patient and parent reports. METHODS: The pedsFACT-BrS for those aged 7 to 18 years was completed by 351 brain tumorpatients (166 children and 185 adolescents), and the parent proxy reports were completed by 351 mother proxies and 37 father proxies. Statistical analyses, including the Pearson product-moment correlation coefficient, intraclass correlation, and comparison of group means, were used to compare the 33 items shared by all 4 versions of the pedsFACT-BrS. RESULTS: The correlation between reports completed by pediatric patients and their parent proxies was significant (P=.59-.84), whereas that between the reports of adolescent patients and their parent proxies was slightly weaker (P=.47-.78). The patient and parent proxy reports showed moderate-to-good agreement and yielded similar mean scores in both the child and adolescent brain tumorpatient groups; the sole exception was a difference in emotional well-being scores. CONCLUSIONS: The results indicate that proper use of the pedsFACT-BrS for patients and their parent proxies can provide clinicians with valid information about the overall QOL of child and adolescent brain tumorpatients, including both their general health and their brain tumor-specific well-being. Copyright (c) 2010 American Cancer Society.
Authors: Samantha J Anthony; Enid Selkirk; Lillian Sung; Robert J Klaassen; David Dix; Katrin Scheinemann; Anne F Klassen Journal: Qual Life Res Date: 2013-08-02 Impact factor: 4.147
Authors: Bree R Eaton; Saveli Goldberg; Nancy J Tarbell; Miranda P Lawell; Sara L Gallotto; Elizabeth A Weyman; Karen A Kuhlthau; David H Ebb; Shannon M MacDonald; Torunn I Yock Journal: Neuro Oncol Date: 2020-09-29 Impact factor: 12.300
Authors: J Vetsch; C E Wakefield; E G Robertson; T N Trahair; M K Mateos; M Grootenhuis; G M Marshall; R J Cohn; J E Fardell Journal: Qual Life Res Date: 2018-01-25 Impact factor: 4.147
Authors: Bryce B Reeve; Molly McFatrich; Laura C Pinheiro; Meaghann S Weaver; Lillian Sung; Janice S Withycombe; Justin N Baker; Jennifer W Mack; Mia K Waldron; Deborah Gibson; Deborah Tomlinson; David R Freyer; Catriona Mowbray; Shana Jacobs; Diana Palma; Christa E Martens; Stuart H Gold; Kathryn D Jackson; Pamela S Hinds Journal: Pediatr Blood Cancer Date: 2016-09-21 Impact factor: 3.167
Authors: Karen A Kuhlthau; Margaret B Pulsifer; Beow Y Yeap; Dianali Rivera Morales; Jennifer Delahaye; Kristen S Hill; David Ebb; Annah N Abrams; Shannon M Macdonald; Nancy J Tarbell; Torunn I Yock Journal: J Clin Oncol Date: 2012-05-07 Impact factor: 44.544
Authors: Hyeon Jin Park; Hyung Kook Yang; Dong Wook Shin; Yoon Yi Kim; Young Ae Kim; Young Ho Yun; Byung Ho Nam; Smita Bhatia; Byung Kiu Park; Thad T Ghim; Hyoung Jin Kang; Kyung Duk Park; Hee Young Shin; Hyo Seop Ahn Journal: J Korean Med Sci Date: 2013-11-26 Impact factor: 2.153